Screener / SEC EDGAR /CIK 0001830033 /10-K filed Feb 26, 2026, compared with Feb 27, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq, OTC Materials · Plastics & Resins

PureCycle Technologies, Inc. PCT

Compare with peers Embed
SEC comment letters, last 20 years

3 reviews of PCT's filings by SEC staff

UPLOAD and CORRESP
Reviews 3 latest letter Dec 6, 2024
Questions asked 75 each answered in the company's own letter
No closing letter 3 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 6 UPLOAD
  2. 2. Questions in them 75 numbered comments
  3. 3. Company replies 5 CORRESP
  4. 4. Reviews closed 0 of 3 closing letter

Form S-3

2024-12-06 to 2025-01-13 · 2 questions · 2 letters from the SEC, 2 from the company
No closing letter
SEC asked
We note your disclosure that the Selling Stockholders may sell the 50,000 Preferred Shares being registered for resale “on the principal trading market for such securities or any other stock exchange, market or trading facility on which the securities are traded or in private transactions” and that “[t]hese sales may be at fixed or negotiated prices.” We also note, however, that the Preferred Shares do not appear to
Rest of the question

be traded on any existing trading market for purposes of Item 501(b)(3) of Regulation S- K. Accordingly, please revise to disclose a fixed price at which the Selling Stockholders will offer and sell the Preferred Shares for the duration of the offering or until they are listed or quoted on a trading market, or otherwise explain how you will comply with Item 501(b)(3).

PCT answered
We acknowledge the Commission’s request that we revise the prospectus contained in the Registration Statement to disclose a fixed price at which the Selling Stockholders will be reselling their shares of Preferred Shares. However, Instruction 2 to Item 501(b)(3) of Regulation

S-K provides that “if it is impracticable to state the price to the public” the issuer must “explain the method by which the price is to be determined.” The Preferred Shares may be resold to the public by the Selling Stockholders at various times and in various privately negotiated manners, thereby making it
Rest of the answer

impracticable for the Company to state in the Registration Statement the price at which the Preferred Shares will be sold to the public.

The Company respectfully advises the Staff that the outside cover page to the prospectus contained in the Registration

Statement has been amended to include the following disclosure: “The Selling Stockholders may sell or otherwise dispose of the Common Shares and Preferred Shares covered by this prospectus in a number of different ways and at varying prices.

The Selling Stockholders may offer and sell shares of Preferred Stock or shares of Common Stock in public or private transactions, or both. These sales may occur at fixed prices, at prices related to prevailing market prices, or at negotiated prices, or, in the case of sales of our Common Stock, at market prices prevailing at the time of sale. There is no established public trading market for our Preferred Stock. We provide more information about how the Selling Stockholders may sell or otherwise dispose of the Common Shares and Preferred Shares covered by this prospectus in the section entitled “Plan of Distribution” beginning on page 32.”

The section entitled “Plan of Distribution” has been revised in the amendment to the Registration Statement to explain that

“[t]here is no public trading market for the Preferred Shares, and we do not expect a public trading market to develop. We do not intend to apply for listing of the Preferred Shares on any securities exchange, quotation system or other recognized trading system. The prices at which the Preferred Shares may be sold will be determined in privately negotiated transactions and depend, in part, on the manner and timing of such sales.”

Read in the reply
SEC asked
We note your response to comment 1 and reissue the comment. The resale offering of Preferred Shares must be conducted in compliance with Rule 415(a)(1)(i) of the Securities Act and Item 501(b)(3) of Regulation S-K. Because there is no trading market for the Preferred Shares, their resale cannot be conducted at a market price or at a formula related to the market price.
Rest of the question

Accordingly, please revise to disclose the fixed price at which the Preferred Shares will be offered for the duration of the offering or until they are listed or quoted on a market. If you are not able to state a price, please revise to explain a particular method or formula by which the price is to be determined. Refer to Instruction 2 to Item 501(b)(3) of Regulation S-K.

PCT answered
The Company hereby requests that the effective date and time of the above referenced Registration Statement be accelerated to 4:00 p.m. on January 15, 2025 or as soon thereafter as practicable, pursuant to Rule 461 of the Securities Act of 1933, as amended.
Read in the reply

Form S-1

2021-01-21 to 2021-01-26 · 3 questions · 1 letter from the SEC, 1 from the company
No closing letter
Acquisitions
SEC asked (1)
Our oral comment sought your analysis regarding whether it was appropriate to include the the resale of the shares to be received by the investors in the PIPE transaction which is not yet completed. We referred you to Securities Act Section 5 Compliance & Disclosure Interpretation ("CD&I") No. 139.11.
Rest of the question

We understand from your oral response that you believe the investors are irrevocably bound to purchase the PIPE shares. We note from our discussion and disclosure in the registration statements, that filing this registration statement within 10 days of filing the Form S-4 registration statement was a condition of the PIPE transaction, and that this condition was included, at least in part, to avoid any delay of the resale registration statement related to potential staff review. Confirm, if true, that you do not intend to seek acceleration of this registration statement until the reorganization transaction describe in the related S-4 is completed. If that is not accurate, please advise. In this regard, we note that although the legal opinion addresses legality of the shares of the resulting company, after the business combination transaction, the cover page of this registration statement names Roth as the issuer (with a note regarding the name change upon closing), and speaks to the S-4 business combination transaction as a future event. Once the business combination transaction has closed, revise this registration statement, particularly the cover page, to clarify the issuer of the shares and the description of the shares offered for sale, reflecting the consummation of the transaction. Also revise the legal opinion accordingly.

PCT answered
The Company confirms the Staff’s understanding regarding the negotiations concerning the timing of initial filing of the

Registration Statement as discussed with the Staff: the PIPE investors sought to have the resale Registration Statement filed prior to the closing date of the Business Combination to allow sufficient time to respond to any issues noted by the Staff in its review of the Registration Statement with a view towards effectiveness on the closing date as contemplated by the PIPE Registration

Rights Agreement.
Rest of the answer

The Company confirms it does not intend to seek acceleration of the Amended Registration Statement until the

Business Combination is completed, although it would request the Staff’s flexibility regarding providing acceleration requests in this regard pursuant to Securities Act Rule 461 in advance of the closing date so that the Amended Registration Statement may be declared effective upon confirmation of filing of relevant merger documentation (including the Combined Company’s Amended and Restated Certificate of Incorporation (the “A&R CoI”)) with the Delaware Secretary of State. In this regard, the Company would not request acceleration pursuant to Rule 461 until it had determined that the stockholders of ROCH had approved the Business Combination, the full amount of proceeds in respect of the PIPE Investment was being held in escrow under the relevant

Subscription Agreements and the NASDAQ Stock Market had approved the Combined Company’s application for listing of the shares, warrants and units to be issued in the Business Combination. Furthermore, should any issues arise on the closing date, the Company would promptly inform the Staff prior to effectiveness and withdraw the acceleration request to allow appropriate updating disclosures to the Registration Statement.

The legal opinion addressing the legality of the shares registered for resale pursuant to the Registration Statement concerns the shares to be issued by Roth CH Acquisition I Co. Parent Corp., the current registrant and the proposed issuer of such shares.

Aside from the change in name, the adoption of the A&R CoI in the RH Merger step of the Business Combination has no effect on the applicability of the legal opinion or the validity of the shares it covers. The Company currently intends to file both a final prospectus pursuant to Rule 424(b) and a “super 8-K” regarding the closing of the Business

Combination under the name “PureCycle Technologies, Inc.” These filings will result in the EDGAR filings for Roth

CH Acquisition I Co. Parent Corp. - including the Registration Statement - all appearing under “PureCycle Technologies,

Inc.” as is customary for SPACs that have completed their business combination. To the extent the Staff so requires,

Loeb & Loeb LLP would be willing to refile the validity opinion promptly after the closing of the Business Combination using the name “PureCycle Technologies, Inc.” and without assuming the consummation thereof on a post-effective amendment pursuant to Rule 462(d).

Appropriate changes to characterize the Business Combination in the appropriate tense so that the Amended Registration Statement will be accurate upon effectiveness in response to the Staff’s comment are reflected on the cover pages of the Registration

Statement and the Prospectus, the Explanatory Note and pages 5-6, 7-10, 17, 19-20, 40, 49, 50, 66, 107-108, 110, and 128 of the Amended Registration Statement. As noted above, in the event of unforeseen issues arising from the Special Meeting or the closing of the Business Combination (including regarding any material waivers granted in connection therewith), the Company undertakes to promptly revise the Amended Registration Statement prior to effectiveness so that updating disclosures may be included and provide the Staff time for review prior to any renewed request for acceleration of effectiveness.

Read in the reply
SEC asked (2)
Continue to revise the document in light of the comments on the related Form S-4, including updating the executive and director compensation information for the year ended December 31, 2020.
PCT answered
Changes in response to the Staff’s comment and to conform to changes contained in the recently amended related Form S-4 are reflected on pages 11, 23, 32-33, 49-50, 61, 66, 68, 70-72, 76, 78-83, 87-89, 98-101, 103, 105-110, 112, 117-118, and 124-125 of the Amended Registration Statement.

Selling Stockholders,
Read in the reply
Selling Stockholders, page 120
SEC asked (3)
Please identify the natural person or persons who directly or indirectly exercise sole or shared voting and/or dispositive power with respect to the shares held by the trusts and other entities identified in the table. Refer to Item 403 of Regulation S-K.
Rest of the question

We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement.

PCT answered
Changes in response to the Staff’s comment are reflected on pages 119-123 of the Amended Registration Statement.
Read in the reply

Form S-4

2020-12-17 to 2021-02-03 · 70 questions · 3 letters from the SEC, 2 from the company
No closing letter
AcquisitionsRisk factorsIncome taxesResults discussion (MD&A)Executive payRevenueLiquidity and cashLegal and contingenciesLeasesDerivatives and hedging
Questions and Answers About the Proposals, page ix
SEC asked (1)
Please provide your analysis as to why you are not required to unbundle those changes to your charter which are not specific to special purpose acquisition companies into separate proposals. Refer to Rule 14a-4(a)(3) of Regulation 14A as well as Question 201.01 of the Division’s Exchange Act Rule 14a-4(a)(3) Compliance and Disclosure Interpretations.
PCT answered
The

Company believes the structure of the business combination (the “Business Combination”) contemplated by the

Agreement and Plan of Merger does not require any changes to the charter of Roth CH Acquisition I Co. (the

“SPAC”), which is the registrant that will be soliciting the approval of its stockholders of the Business

Combination, other than those specific to the change in status from that of a publicly-traded special purpose acquisition company to an intermediate subsidiary holding company.
Rest of the answer

The form of Amended and Restated Certificate of Incorporation of

PureCycle Technologies, Inc. appearing as Annex C to the Merger Agreement is the charter that will be adopted by the Company, a newly-formed entity created to effect the “double dummy” acquisition of PCT by the SPAC. While the Company recognizes that Question 201.02 regarding the Staff’s views concerning unbundling in the context of the introduction of a new entity might apply in circumstances where stockholders of the SPAC are expected to own the largest percentage of equity securities of the new entity following consummation of the transaction, based on the expected percentages reflected in the charts shown on pages 8 and 45 of the Amended Registration Statement, the former stockholders of the SPAC are expected to own less than 10% of the equity securities of the Company, and in fact may own substantially less should a significant number of stockholders of the SPAC elect to exercise their redemption rights. With due regard to the Staff’s views that public stockholders should not be presented with complex proposals that could deprive them of an opportunity to consider points that—as a result of state law, the rules of a national securities exchange, or an entity’s organizational documents—require their approval, where the SPAC stockholders will not control the Company, which is the post-Business

Combination entity, and the consent of the SPAC’s stockholders is not required in connection with the organizational documents of the successor to be in effect following the Business Combination, the Company believes that the

Staff’s guidance with respect to unbundling is not applicable.

Read in the reply
Questions and Answers About the Proposals, page ix
SEC asked (2)
Highlight how much of the vote is locked up by the various agreements between the initial stockholders, owners of PCT and/or others.
PCT answered
The Company notes that only stockholders of record of the SPAC as of the record date to be established regarding the special meeting to approve the Business Combination will be entitled to vote to approve the Business Combination. PCT securityholders (including investors in the Pre-PIPE Financing (as defined in the Amended Registration Statement)) and PIPE investors (as defined in the Amended Registration

Statement) will not be entitled to vote at the special meeting of stockholders of the SPAC and the Company believes that the references under “How Will the Initial Stockholders Vote?” on
Rest of the answer

page x and “Record Date; Who is Entitled to Vote” on page 41 of the Amended Registration Statement to approximately 22.2% of the shares held by such stockholders reflects how much of the vote is locked up by the agreements entered into concurrently with the Merger Agreement.

Read in the reply
Questions and Answers About the Proposals, page ix
SEC asked (3)
We note disclosure on page xi about the deferred underwriting commissions and the amounts disclosed on pages 135 and 136. In an appropriate section of the document, please disclose whether or not any of your representatives that were part of the diligence or negotiations with PCT are owed or entitled to any of the deferred IPO underwriting fees.
PCT answered
Changes in response to the

Staff’s comment are reflected on pages xi, 29, 66-67, 140, 142 and 160 of the Amended Registration Statement.
Read in the reply
Summary, page 1
SEC asked (4)
Clarify why shareholders are not being given the ability to elect the directors to hold office after the business combination. Clarify when and by whom new directors, such as Mr. Otworth, will be nominated to the board, as disclosed on page 122.
Rest of the question

Revise the summary to clarify what provisions govern the selection of these directors and which directors are designees of the investor rights agreement, as disclosed on page 157. Provide a risk factor that highlight the public shareholders’ inability to effectively participate in the election of directors for the period of time during which the Investor Rights Agreement and Company Support Agreement allow the votes to remain locked up. Summary

PCT answered
Changes in response to the Staff’s comment are reflected on pages 6 and 39 of the Amended Registration Statement. Similar to the response to Comment

1 above, the stockholders of the SPAC have no right under Delaware law to elect directors of a different corporation and if they are dissatisfied with the proposed members of the combined company board of directors they may elect to exercise their redemption rights.
Rest of the answer

The Company also notes that a business combination involving a special purpose acquisition company is similar in many respects to an initial public offering of stock in the target company, and that IPO investors are typically not afforded an opportunity to vote on board members until the first annual meeting of stockholders after the IPO has been consummated.

Read in the reply
The Special Meeting, page 1
SEC asked (5)
On page 3 you disclose that Roth Capital Partners, LLC and Craig-Hallum will receive “certain offering related expenses.” Revise the summary to highlight and clarify the relationship of the ROCH CEO and CFO, Messrs. Byron Roth and Gordon Roth to Roth Capital Partners, LLC. Also Clarify Mr. Gurewitz’ relationship to Roth Captial Partners, LLC. Also revise to disclose Mr. Hartfiel and Mr.
Rest of the question

Lipman’s relationship to Craig-Hallum and Mr. Friedberg’s relationship to Sagard Captial Partners. Disclose in the summary the potential conflicts of interest and the extent to which these individuals will benefit from this transaction through their relationship with these entities in addition to their status as initial stockholders and/or directors. Disclose to what extent any of these individuals were involved in the due diligence and negotiations.

PCT answered
Changes in response to the Staff’s comment are reflected on pages xi, 3-4, 29, 55, 140, and 160 of the Amended Registration Statement. As noted on pages 157-158 of the Amended Registration Statement, Mr. Friedberg is no longer affiliated with Sagard Capital

Partners.
Read in the reply
Risk Factors, page 18
SEC asked (6)
On pages 30-31, identify what conditions of the merger ROCH may waive without shareholder approval. Clarify whether ROCH may waive the condition of the merger that the shares be approved for listing on the Nasdaq. If so, provide a separate risk factor highlighting the risks associated with such a waiver.
PCT answered
Changes in response to the Staff’s comment are reflected on page 31 of the Amended Registration Statement.
Read in the reply
Risk Factors, page 18
SEC asked (7)
We note the risk factor on page 29 addressing potential conflicts of interest of the Initial Stockholders. Clarify, as discussed on page 133, that each of ROCH’s directors and officers is an Initial shareholder. Revise to address all the potential conflicts of interest, including those discussed on pages 62 and 133.
Rest of the question

The exercise of registration rights or sales of a substantial amount of the Combined Company’s Common Stock after the Business Combination m, page 33

PCT answered
Changes in response to the

Staff’s comment are reflected on pages 29 and 140 of the Amended Registration Statement.

The exercise of registration rights or sales of a substantial amount of the Combined Company’s Common Stock after the Business Combination m, page 33
Read in the reply
Risk Factors, page 18
SEC asked (8)
State the total number of shares that will be available for registration and sale.
PCT answered
Changes in response to the

Staff’s comment are reflected on page 34 of the Amended Registration Statement.
Read in the reply
Proposal No. 1—The Business Combination Proposal, page 44
SEC asked (9)
Revise page 46 to briefly describe “closing legal impediment.”
PCT answered
Changes in response to the Staff’s comment are reflected on page 46 of the Amended Registration Statement.
Read in the reply
Proposal No. 1—The Business Combination Proposal, page 44
SEC asked (10)
On page 54, you state in several of your summaries of the various agreements that each is “qualified in its entirety by reference to the full text” of the agreement. It is not appropriate for you to qualify your disclosure by reference to information that is not included in the prospectus or filed as an exhibit to the registration statement.
Rest of the question

Please revise these statements and similar disclaimers throughout the document accordingly. Background of the Merger, page 56

PCT answered
Changes in response to the

Staff’s comment are reflected on pages 44, 54 and 72 of the Amended Registration Statement.
Read in the reply
Proposal No. 1—The Business Combination Proposal, page 44
SEC asked (11)
On page 56, balance the disclosure of the ROCH team’s “proven track record of both operational and financial success” with the risk that this endeavor may not succeed.
PCT answered
Changes in response to the

Staff’s comment are reflected on pages 56-57 of the Amended Registration Statement.
Read in the reply
Proposal No. 1—The Business Combination Proposal, page 44
SEC asked (12)
Please substantially revise your disclosure to provide additional detail, including timing, regarding the search process, including whether and how ROCH sought indications of interest, how it identified potential targets, how it selected which potential target companies to review, describe the process of identifying the 25 companies with which it entered into “detailed substantive discussions,” the progress of those
Rest of the question

negotiations, whether and if so, how many, entered into non-disclosure agreements, and additional detail regarding when and why either ROCH or the other party ceased negotiations, and how the discussions with other potential targets overlapped with one another and with PCT. In doing so, describe the potential terms discussed, the progress of those discussions, the assumed valuations of ROCH and each potential target, the proposed ownership proportions, and any revised proposals. Also provide the dates of board meetings at which the management team communicated with the board, how many candidates they presented to the board, what recommendations they made, whether financial advisors were involved, and further information on the board’s decision-making process.

PCT answered
The Amended Registration Statement contains a substantially revised “Background of the Merger” section appearing on pages

56-63 addressing the points raised in the Staff’s comment.
Read in the reply
Proposal No. 1—The Business Combination Proposal, page 44
SEC asked (13)
Clarify what prompted discussions with PCT and the timing for their start in relation to the other target companies considered. In doing so, explain the role of Innventure, LLC, in ROCH’s search for acquisition targets and what role Mr. Balkin played to that end, including why it was he who contacted Mr. Roth, and why he did so. We note that Innventure is an affiliate of PCT. Further clarify the relationship.
PCT answered
Changes in response to the

Staff’s comment are reflected on pages 57-58 of the Amended Registration Statement.
Read in the reply
Proposal No. 1—The Business Combination Proposal, page 44
SEC asked (14)
Clarify the distinction between “ROCH and ROCH’s management,” to which you refer in the discussions surrounding the July 8-15 due diligence of PCT using publicly available information. We note from page 134 that ROCH has five officers.
PCT answered
Changes in response to the Staff’s comment are reflected on pages 57-58 of the Amended Registration Statement.
Read in the reply
Proposal No. 1—The Business Combination Proposal, page 44
SEC asked (15)
We note from the risk factor on page 19, that ROCH reviewed certain projected financial information provided by PCT. Please revise to disclose such projections and discuss all material assumptions used to develop the projections. Also discuss the possible impact if the projections are not correct. Clarify when the projections were provided.
PCT answered
Changes in response to the

Staff’s comment are reflected on pages 63-65 of the Amended Registration Statement.
Read in the reply
Proposal No. 1—The Business Combination Proposal, page 44
SEC asked (16)
Clarify what PCT disclosed to the ROCH board or management team about their negotiations with other SPACs and/or other potential combination partners.
PCT answered
Changes in response to the

Staff’s comment are reflected on page 58 of the Amended Registration Statement.
Read in the reply
Proposal No. 1—The Business Combination Proposal, page 44
SEC asked (17)
In the fifth paragraph on page 58, you state ROCH and PCT entered into a “non-exclusive letter of intent . . . to pursue a business combination.” Revise to disclose more information about the content and nature of that agreement.
PCT answered
Changes in response to the Staff’s comment are reflected on page 59 of the Amended Registration Statement.
Read in the reply
Proposal No. 1—The Business Combination Proposal, page 44
SEC asked (18)
Clarify why counsel for ROCH sent the initial draft merger agreement to “C-H to be forwarded to PCT and its counsel Jones Day,” and C-H’s role in the negotiations.
PCT answered
Changes in response to the

Staff’s comment are reflected on page 59 of the Amended Registration Statement.
Read in the reply
Proposal No. 1—The Business Combination Proposal, page 44
SEC asked (19)
Clarify whether the revised LOI, amended on October 5, 2020, remained “nonexclusive.” Clarify when PCT began the process of obtaining the revenue bond, and how and why that affected the merger consideration. Clarify PCT’s use of the proceeds of the revenue bond and the note purchase agreement.
Rest of the question

Revise to provide further detail of the purpose for and content of the new provisions added to the LOI when it was further amended on October 8, 2020.

PCT answered
Changes in response to the

Staff’s comment are reflected on page 60 of the Amended Registration Statement.
Read in the reply
Proposal No. 1—The Business Combination Proposal, page 44
SEC asked (20)
Substantially revise the disclosure of negotiations with PCT, and in particular the disclosure of events between October 13 and November 16, 2020, when the parties negotiated the terms of the merger agreement, to provide details regarding the negotiations that led to the finalization of the key terms of the proposed business combination.
Rest of the question

For example, it is not clear how the parties determined the type and amount of consideration or the forms of consideration. Expand your discussion of the merger agreement to identify the material terms negotiated and discuss how the issues were resolved, including changes in any terms favorable to ROCH’s management and affiliates as compared to the public shareholders. In addition, provide additional detail regarding the negotiation of PCT managements’ employment contracts, including Mr. Otworth’s $5 million bonus discussed on page 125.

PCT answered
Changes in response to the

Staff’s comment are reflected on pages 61-63 of the Amended Registration Statement.
Read in the reply
Proposal No. 1—The Business Combination Proposal, page 44
SEC asked (21)
Name the “independent engineering firm that prepared the independent report on PCT,” the nature of that report, and for what purpose ROCH management sought the report. File the firm’s consent and its opinion as exhibits. Revise the background of the merger to summarize the report in the document.
PCT answered
Changes in response to the

Staff’s comment are reflected on pages 2, 3, 46, 54, 59, 61, 190, 194 and the Exhibit Index of the Amended Registration

Statement. While PCT has received Leidos’ consent to be named in the Registration Statement, PCT is still considering redactions of certain information from the Leidos Report that it believes is, among other things, immaterial to stockholders of ROCH voting on the proposals at the Special Meeting. PCT has undertaken to provide such appropriately redacted Leidos Report in the next amendment to the Registration Statement.
Rest of the answer

The Company supplementally advises the Staff that PCT will file a Confidential Treatment Request for portions of the Leidos Report.

Read in the reply
Proposal No. 1—The Business Combination Proposal, page 44
SEC asked (22)
Clarify what was discussed at the November 10, 2020, board meeting, whether the merger agreement changed as a result of that meeting or what changes were needed to the merger agreement at that point which prompted a delay in the vote.
PCT answered
Changes in response to the Staff’s comment are reflected on page 62 of the Amended Registration Statement.
Read in the reply
Proposal No. 1—The Business Combination Proposal, page 44
SEC asked (23)
Revise this section to disclose ROCH’s financial analyses of the comparable companies, transactions and other analysis upon which the board relied in reaching its decision. In doing so, provide the material assumptions underlying the analysis, including the criteria used to select comparable companies and/or transactions.
PCT answered
Changes in response to the Staff’s comment are reflected on pages 58-59 of the Amended Registration Statement.

Material U.S. Federal Income Tax Considerations,
Read in the reply
Material U.S. Federal Income Tax Considerations, page 80
SEC asked (24)
On page 81, you state that the disclosure is “for informational purposes only and is not tax advice” and that investors should “consult their own tax advisors regarding the tax consequences” of various aspects of the transaction. Investors are entitled to rely on your disclosure. Revise to eliminate these inappropriate disclaimers.
Rest of the question

You may recommend that investors consult their own advisors with respect to the personal tax consequences of the transactions, which may vary. For guidance, refer to Section III.D. of Staff Legal Bulletin No. 19.

PCT answered
Changes in response to the

Staff’s comment are reflected on page 85 of the Amended Registration Statement.
Read in the reply
Material U.S. Federal Income Tax Considerations, page 80
SEC asked (25)
We note from page 81 that you “expect” the exchange of shares pursuant to the merger “to qualify as a non-recognition . . . “reorganization” and that the federal tax consequences for the warrants are “uncertain.” Revise to eliminate the statement “assuming such qualification” and the “generally” description and similar qualifiers.
Rest of the question

Revise this section to describe the material tax consequences, and, to the extent counsel is unable to opine, so state, provide the reasons why counsel cannot opine, and expand your discussion of the possible alternatives to provide additional detail and to avoid merely providing a description of the law. In doing so, describe the degree of uncertainty of the tax treatment of the warrants. For guidance, refer to Section III.C. of Staff Legal Bulletin No. 19. Description of PCT Business, page 89

PCT answered
Changes in response to the

Staff’s comment are reflected on pages 9, 85-87, and 89 of the Amended Registration Statement.
Read in the reply
Material U.S. Federal Income Tax Considerations, page 80
SEC asked (26)
Revise to provide the information on the principal holders of PCT securities as required by Item 18(a)(5)(ii) of Form S-4, which refers to Item 6 of Schedule 14A, which requires disclosure pursuant to Item 403 of Regulation S-K.
PCT answered
The Company acknowledges the Staff’s comment and, following discussion with PCT and its counsel, advises the Staff that a year-end redistribution of PCT units is currently being effected that will affect such percentage ownership figures. PCT has undertaken to provide fully compliant Item 403 information for inclusion in the next amendment to the Registration Statement.
Read in the reply
Material U.S. Federal Income Tax Considerations, page 80
SEC asked (27)
You state PCT is “regarded as a ‘leader’ in innovation in polymers, sustainability, and recycling” by several organizations, although it has yet to begin commercial production, as explained on page 96. Please further substantiate or clarify your claim of leadership or revise this and similar disclosure to state this as your beliefs.
PCT answered
Changes in response to the

Staff’s comment are reflected on pages 93 and 106 of the Amended Registration Statement.
Read in the reply
Material U.S. Federal Income Tax Considerations, page 80
SEC asked (28)
Revise to provide additional information about the nature of the “strategic partnerships” and collaborations disclosed in the chart on page 93, and your expectations regarding those partnerships after the business combination.
PCT answered
Changes in response to the

Staff’s comment are reflected on page 97 of the Amended Registration Statement.
Read in the reply
Government Regulation, page 97
SEC asked (29)
Substantially revise this section to further describe the various regulations that apply to your products and/or their sourcing and manufacture.
PCT answered
Changes in response to the

Staff’s comment are reflected on pages 25-26 and 101-104 of the Amended Registration Statement.
Read in the reply
Government Regulation, page 97
SEC asked (30)
Revise to clarify on what basis you expect the FDA will provide a letter of no objection in 2021, to allow PCT’s product to be used in food-grade applications. Clarify the various categories of feedstock for which you will seek no objection letters.
Rest of the question

Explain the process for doing so, including where in the process individual migration studies may be required and the anticipated overall timeframe for obtaining a no objection letter. Intellectual Property, page 98

PCT answered
Changes in response to the

Staff’s comment are reflected on pages 25-26 and 101-102 of the Amended Registration Statement.
Read in the reply
Government Regulation, page 97
SEC asked (31)
You disclose that there are nine granted and four pending utility patents licensed from P&G. Revise to clarify what aspects of your business the utility patents address. Disclose the volume and geographic restrictions on P&G’s ability to license the technology to others. PCT Management’s Discussion and Analysis of Financial Condition and Results of Operations,
PCT answered
Changes in response to the Staff’s comment are reflected on page 104 of the Amended Registration Statement.
Read in the reply
Government Regulation, page 97
SEC asked (32)
Revise to give a range of the P&G royalty rates to within 10 percentage points.
PCT answered
Changes in response to the

Staff’s comment are reflected on page 108 of the Amended Registration Statement.
Read in the reply
Contractual Obligations and Commitments, page 112
SEC asked (33)
You disclose future operating lease obligations here for PCT’s Lawrence County, Ohio property, yet on pages 98 and 129 you state a subsidiary of PCT purchased that land from Innaventure LLC, a related party. Please clarify.
PCT answered
Changes in response to the

Staff’s comment are reflected on pages 119-120 of the Amended Registration Statement.

ROCH Management’s Discussion and Analysis of Financial Condition and Results of Operations Liquidity and Capital Resources, page 135
Read in the reply
ROCH Management’s Discussion and Analysis of Financial Condition and Results of Operations · Liquidity and Capital Resources, page 135
SEC asked (34)
Revise page 136 to clarify, if true, that no loans from ROCH board members or management are currently outstanding. Unaudited Pro Forma Condensed Combined Financial Information Notes to Unaudited Pro Forma Condensed Combined Financial Information 3. Adjustments to Unaudited Pro Forma Condensed Combined Financial Information, page 146
PCT answered
Changes in response to the

Staff’s comment are reflected on page 160 of the Amended Registration Statement.

Unaudited Pro Forma Condensed Combined Financial

Information

Notes to Unaudited Pro Forma Condensed Combined Financial

3. Adjustments to Unaudited Pro Forma Condensed Combined
Read in the reply
ROCH Management’s Discussion and Analysis of Financial Condition and Results of Operations · Liquidity and Capital Resources, page 135
SEC asked (35)
Refer to balance sheet adjustment (J). Please explain to us why you have classified the net proceeds from the issuance of Revenue Bonds as a current asset when construction of the Phase II Facility will continue through October 2022.
PCT answered
Changes in response to the

Staff’s comment are reflected on page 149 of the Amended Registration Statement.
Read in the reply
ROCH Directors and Management, page 149
SEC asked (36)
Clarify for what “Roth” entity Messrs. Byron Roth and Gordon Roth have been employed since 1998 and 2000, respectively
PCT answered
Changes in response to the

Staff’s comment are reflected on page 156 of the Amended Registration Statement.
Read in the reply
ROCH Executive Compensation, page 152
SEC asked (37)
You state that “[n]o ROCH executive officer has received any cash compensation.” Clarify whether any executive officer or director has received any cash or other form of compensation. To the extent you reimburse for out-of-pocket expenses, for which there is no limit and no review other than by the board or in court, provide us your analysis why these amounts are not compensation and not required to be disclosed
Rest of the question

pursuant to Item 402 of Regulation S-K.

PCT answered
Changes in response to the

Staff’s comment are reflected on page 159 of the Amended Registration Statement. The Company supplementally advises the

Staff that each expense for which the SPAC reimburses its executive officers and directors is “integrally and directly related” to the performance of their duties. As noted in Section II.C.1.e.i of SEC Release No.
Rest of the answer

33-8732A, “[a]n item is not a perquisite or personal benefit if it is integrally and directly related to the performance of the executive’s duties.” The Company and the SPAC believes that the search for a business combination target, attendance at Board, committee and stockholder meetings and similar activities are clearly ‘integrally and directly related’ to the performance of such individual’s duties, and that reimbursement for related expenses—travel, lodging and reasonable out-of-pocket expenses—is therefore neither compensation nor a personal benefit or perquisite.

Read in the reply
Certain Relationships and Related Party Transactions of ROCH, page 153
SEC asked (38)
Disclose which person or persons are related to Roth Capital Partners, LLC and describe the relationship(s). Revise to clarify if, like the potential loans discussed on page 136, there is an understanding that this loan will be repaid upon consummation of the business combination.
PCT answered
Changes in response to the
Read in the reply
Certain Relationships and Related Party Transactions of ROCH, page 153
SEC asked (39)
Provide your analysis of why the following are not required to be disclosed here: (1) the ROCH directors’ relationships with entities who will receive fees related to this transaction; and (2) Mr. Fiegler’s agreement to purchase 1 million shares of ROCH common stock in the PIPE transaction, as disclosed on page 156.
PCT answered
Changes in response to the

Staff’s comment are reflected on page 160 of the Amended Registration Statement. The Company respectfully advises the Staff that it believes that the relationships between the individuals and entities involved in the Business Combination from Roth Capital

Partners, LLC and Craig-Hallum Capital Group LLC are clearly described in both the SPAC’s IPO prospectus and in the Amended

Registration Statement, but in the interests of enhancing a stockholder’s appreciation of these relationships has included additional disclosure in this regard under this heading. Mr.
Rest of the answer

Fieler’s agreement to buy shares in the PIPE is disclosed as a Company related party transaction on page 164 of the Amended

Registration Statement. Mr. Fieler has no affiliation with ROCH.

Read in the reply
Description of the Combined Company's Capital Stock · Exclusive Forum Selection, page 172
SEC asked (40)
We note that your forum selection provision in Article XI of the charter, on page C-6, identifies the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain litigation, including any “derivative action.” We note that “the provisions of this Article X will not apply to suits brought to enforce any liability or duty created by the Securities Exchange Act of 1934.” First, clarify whether
Rest of the question

that reference in the charter should be to Article XI, rather than Article X. In addition, please disclose whether this provision applies to actions arising under the Securities Act. In that regard, we note that Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder, and Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. If the provision applies to Securities Act claims, please also revise your prospectus to state that there is uncertainty as to whether a court would enforce such provision and that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. If this provision does not apply to actions arising under the Securities Act, please also ensure that the exclusive forum provision in the charter states this clearly, or tell us how you will inform investors in future filings that the provision does not apply to any actions arising under the Securities Act.

PCT answered
Changes in response to the

Staff’s comment are reflected on pages 179 and C-6 of the Amended Registration Statement.
Read in the reply
Comparison of Stockholders Rights, page 173
SEC asked (41)
Where the ROCH governing documents provide certain rights or abilities “as provided under the DGCL,” revise this section to briefly explain what the DGCL provided, so that shareholders can understand the differences you outline in this section. Exhibits
PCT answered
Changes in response to the

Staff’s comment are reflected on pages 183 and 184 of the Amended Registration Statement.
Read in the reply
Comparison of Stockholders Rights, page 173
SEC asked (42)
Revise the exhibits to file the actual agreements, rather than the “form of” agreements. Revise the first page of any redacted exhibits, including Exhibit 10.20, to include a prominent statement on the first page of the redacted exhibit regarding the omissions, as required by Item 601(b)(10)(iii) of Regulation S-K.
PCT answered
Changes in response to the

Staff’s comment are reflected in the Exhibit Index to the Amended Registration Statement.
Read in the reply
Comparison of Stockholders Rights, page 173
SEC asked (43)
Provide a form of proxy with your next amendment.
PCT answered
A form of proxy has been included as Exhibit 99.1 to the Amended Registration Statement.
Read in the reply
SEC letter of Jan 14, 2021 ↗ no reply letter on EDGAR (the company may have answered in an amended filing)
Questions and Answers About the Proposals, page ix
SEC asked (1)
We reissue comment 1. We disagree with your analysis. Revise to unbundle the changes to the charter that are not specific to special purpose acquisition companies.
PCT answered

No reply letter found.

Questions and Answers About the Proposals, page ix
SEC asked (2)
We reissue comment 2. Where you address the various agreements, specifically disclose the approximate amount of the vote that is locked up and highlight that fact in the summary.
PCT answered

No reply letter found.

Summary, page 1
SEC asked (3)
We note your revised disclosure in response to comment 4. You added a risk factor related to this disclosure at the end of your section of "General Risk Factors." We disagree with your analysis that this is a general risk applicable to any public company. Revise to move the risk factor to a more appropriate section.
PCT answered

No reply letter found.

The Special Meeting, page 1
SEC asked (4)
We note the revised disclosure in response to comment 5. Revise to disclose the positions held by the named individuals at Roth Captial Partners, LLC and Craig-Hallum Capital Group LLC, rather than referring to the individuals as senior executives. Risk Factors, page 18
PCT answered

No reply letter found.

The Special Meeting, page 1
SEC asked (5)
We reissue comment 6 to the extent that you have not revised the risk factor to identify all the conditions that ROCH may waive without shareholder approval.
PCT answered

No reply letter found.

The Special Meeting, page 1
SEC asked (6)
We reissue comment 7. Revise the risk factor on page 31 or add another risk factor that discloses all the conflicts of interest, including those outlined on pages 62 and 133. Background of the Merger, page 56
PCT answered

No reply letter found.

The Special Meeting, page 1
SEC asked (7)
We reissue comment 12 in full. Your revised disclosure does not address the information sought in our comment, particularly with respect to the ROCH identifying and ruling out the initial 25 potential targets identified just after the IPO.
Rest of the question

To the extent you did revise the disclosure to address the narrowing of options to 3-4 companies between July 1 and August 26, 2020, revise to disclose the total number of target companies still under consideration. You state PCT, EV target and CG Target were addressed at board meetings, but later disclose that HC Target was apparently still under consideration. Further disclose the terms addressed with each of these companies and what transpired at each of the board meetings on June 10, July 7 and July 19 and which candidates were discussed. To the extent you have not done so, revise to disclose the timing and nature of the last contacts with each of EV Target, CG Target, HC Target and any other target still under consideration, ultimately clarifying when PCT became the only target under consideration.

PCT answered

No reply letter found.

The Special Meeting, page 1
SEC asked (8)
We reissue comment 16. We note the added disclosure that "PWP informed ROCH of several key topics to be addressed in reengaging with PCT," which implies the parties had cut off negotiations. Clarify when that happened, which party determined not to pursue the transaction, and disclose the "several key topics" addressed by PWC.
PCT answered

No reply letter found.

The Special Meeting, page 1
SEC asked (9)
We note the revised disclosure on page 59 in response to comment 17. Please also revise to clarify what you mean by a "non-exclusive letter of intent." You abbreviate it as a "letter of intent" or "LOI," which is commonly thought to be exclusive.
Rest of the question

Please further describe the terms of the agreement that render it "non-exclusive" and revise your abbreviation so that it will not be confused with an exclusive letter of intent.

PCT answered

No reply letter found.

The Special Meeting, page 1
SEC asked (10)
We reissue comment 18 to the extent that you have not clarified C-H's involvement in the negotiations, or how they became the go-between between counsel and PCT.
PCT answered

No reply letter found.

The Special Meeting, page 1
SEC asked (11)
We reissue comment 20. Provide the additional detail regarding the background of negotiations with PCT throughout the process, including disclosure of the initial terms and when, how and why they changed over time. For example, explain the proposed terms and conditions PCT and ROCH addressed in the week after July 23, 2020.
Rest of the question

Discuss how the potential PIPE transaction came to be part of the discussion in July, and how and why it changed over time. Further explain the changes to the potential terms of the transaction over time, including quantifying the consideration and how the terms of the PCT management employment agreements evolved.

PCT answered

No reply letter found.

The Special Meeting, page 1
SEC asked (12)
We note the summary disclosure provided in response to comment 23 and reissue the comment. Provide additional detail of the valuations performed and disclose who prepared them.
PCT answered

No reply letter found.

Proposal No. 1--The Business Combination Proposal · Certain PCT Projected Financial Information, page 63
SEC asked (13)
We note the projections and related disclosure added here in response to comment 15. You state that "management of PCT prepared the projections set forth below to present key elements of the forecasts provided to ROCH." On page 64, you describe these as "a summary of the projections." Revise to clarify if you have disclosed all the projections provided to ROCH, or only key elements.
Rest of the question

If you have not provided all projects given to ROCH, revise to include all material projections, provide us all of the projections and tell us why you believe any projections not included in the document are not material. In addition, revise the document to disclose all material assumptions underlying the projections.

PCT answered

No reply letter found.

Material U.S. Federal Income Tax Considerations, page 84
SEC asked (14)
We reissue comment 25 to the extent that your disclosure continues to state what you "expect" the tax consequences to be and what certain consequences "should" be, without describing the degree of uncertainty, such as "more likely than not." Furthermore, as you state the exchange offer should be non-taxable, please provide an opinion of counsel. As stated in comment 25, refer to Section III.C.
Rest of the question

of Staff Legal Bulletin No. 19 for guidance regarding the tax opinion.

PCT answered

No reply letter found.

PCT Executive Compensation, page 128
SEC asked (15)
Revise the disclosure here and with respect to ROCH executive compensation to provide the data for the latest completed fiscal year ended December 31, 2020, as required by Item 402 of Regulation S-K.
PCT answered

No reply letter found.

ROCH Executive Compensation, page 160
SEC asked (16)
We note your response to comment 37. Given there is no limit and these expenses are incurred by those who review them, revise page 160 to clarify that "each expense for which the SPAC reimburses its executive officers and directors is 'integrally and directly related' to the performance of their duties'" and, as such, the reimbursements are not compensation or perquisites.
PCT answered

No reply letter found.

Subscription Agreements and PIPE Registration Rights Agreements, page 55
SEC asked (1)
We reissue comment 10 of our December 17, 2020 letter to the extent you have not eliminated the disclaimer in the last paragraph of this subsection, on page 56. Background of the Merger, page 56
PCT answered
Changes in response to the Staff’s comment are reflected on page 56 of the Amended Registration Statement to remove the disclaimer and conform to similar disclosures elsewhere in the Amended Registration Statement.
Read in the reply
Subscription Agreements and PIPE Registration Rights Agreements, page 55
SEC asked (2)
We reissue comment 7. Further expand your disclosure to more precisely describe how the potential alternative transactions were chosen and eliminated as possibilities. For example, given the broad range of industries of the identified targets, clarify the criteria ROTH used to identify the initial candidates. Disclose the terms proposed to and by EV target on and around July 21, 2020.
Rest of the question

Clarify if any other discussions with EV target took place between July 21 and July 27, when "ROCH informed EV Target that the revisions to preliminary terms received . . . made it unlikely that a transaction could proceed." Disclose the terms presented to the targets in August, as discussed at the top of page 60, including the quantifying the valuations, indebtedness assumed, earnouts and other provisions. Clarify whether there were other alternative acquisition targets under consideration in August beyond PCT, EV Target, DTC Target and HC Target, as you state the discussions "included" those entities.

PCT answered
The Company has endeavored to provide significant additional disclosures regarding the selection process and the narrative chronology addressing the Company’s negotiation process during the summer of 2020 to the extent reliable information was available, including with respect to the consistency of recollections of the individuals at ROCH, PCT and PWP. In the event of differing recollections, the Company relied upon contemporaneous notes, calendar invitations, email and text communications and consistency of the description of events from those individuals.
Rest of the answer

The Company believes the Amended

Registration Statement discloses the material information necessary for a holder of ROCH Common Stock to vote on the matters to be approved at the Special Meeting, including the Business Combination. Specific modifications in response to Comment 2 are reflected on pages 57-60 in the Amended Registration Statement.

Read in the reply
Subscription Agreements and PIPE Registration Rights Agreements, page 55
SEC asked (3)
We note your response to comment 10; however, there are additional reference to C-H not addressed by your response. On page 59, clarify why C-H signed the NDA with Innventure, the PCT affiliate. We note C-H was a placement agent for the PIPE. Tell us whether they prepared any additional analysis for the board related to this transaction and provide us those materials.
Rest of the question

We may have further additional comments after we review those materials.

PCT answered
Changes in response to the Staff’s comment are reflected on page 59 of the Amended Registration Statement. The Company supplementally confirms to the Staff that C-H was not engaged to act as a financial advisor to ROCH, and did not prepare or advise on the materials presented to the ROCH Board of Directors although in the course of preparing and revising the investor presentation used in the PIPE, C-H as placement agent provided a customary level of review and comment on the materials used in the PIPE placement.
Read in the reply
Subscription Agreements and PIPE Registration Rights Agreements, page 55
SEC asked (4)
Refer to comment 11 and comment 20 of our December 17, 2020 letter. Further expand your discussion of the evolution of the PCT transaction. For example, expand on the disclosure at the top of page 58 of the analysis of alternative transactions considered in evaluating PCT. Disclose who gave the ROTH board an overview of the PCT opportunity at the July 19, 2020 board meeting.
Rest of the question

Disclose the valuation parameters discussed with PWP July 21-23, 2020. Further clarify how the PIPE transaction came to be part of the proposed transaction. Clarify how the August 27, 2020 ROCH management visit to the FUE came about. Disclose any terms discussed with PCT prior to July 23, 2020. Clarify what prompted the parties to amend the letter of intent on October 8, 2020 to remove the tax contingencies. Disclose the reasons for the changes reflected in the October and November drafts of the merger agreement that are not obvious from the context, such as how the indebtedness provisions and other thresholds changed and why. Disclose what occurred at the November 12, 2020 board meeting other than the two votes. For example, disclose what consideration the board gave to the vote.

PCT answered
Changes in response to the Staff’s comment are reflected on pages 59-61 and 63-65 of the Amended Registration

Statement to the extent reliable information regarding such details are available. As noted above in response to Comment 2, in certain circumstances the parties may not have a specific record regarding the exact date on which a particular individual may have first suggested the PIPE transaction or arranged the Ironton, Ohio site visit, although in preparing this response letter and the Amended Registration Statement a full review of all relevant records and interview of all
Rest of the answer

individuals involved was conducted. Furthermore, to the extent that we know the reasons and rationale for specific changes in the Merger Agreement that are not obvious from the context, we have added them to the Amended Registration Statement. On the whole, however, each party's allocation of risk and allocation of value, as in any negotiation, explain the changes made by both parties.

Read in the reply
Subscription Agreements and PIPE Registration Rights Agreements, page 55
SEC asked (5)
We note your added disclosure in the first paragraph on page 58, which describes, among other things, an "investor presentation to be used as part of the PIPE Investment" which "led to the initial selection of comparable companies," narrowed down to those most similar to PCT on the criteria discussed.
Rest of the question

Provide us the presentation the Placement Agents prepared for presentation to the potential PIPE investors and revise the disclosure to summarize those materials.

PCT answered
Changes in response to the Staff’s comment to summarize the material presented to potential PIPE investors are reflected on pages 58-59 of the Amended Registration Statement. The Company notes that such information appears as slide 32 in Exhibit 99.2 to the Current Report on Form 8-K filed by ROCH on November 16, 2020.
Read in the reply
Subscription Agreements and PIPE Registration Rights Agreements, page 55
SEC asked (6)
We reissue comment 12. Provide additional details of the valuation analyses performed.
PCT answered
Changes in response to the Staff’s comment to provide initial details regarding the initial valuation analysis that formed the basis of the terms proposed by ROCH to PCT are reflected on page 58 of the Amended Registration Statement.
Read in the reply
Subscription Agreements and PIPE Registration Rights Agreements, page 55
SEC asked (7)
Revise the discussion on page 65 to clarify when and by what means PCT obtained PCT Shareholder Approval of the merger, as defined in the merger agreement, and obtained PCT approval of the board nominee, or will do so.
PCT answered
Changes in response to the Staff’s comment are reflected on page 66 of the Amended Registration Statement to clarify when and by what means PCT will obtain PCT securityholder approval of (1) the Merger Agreement, related transaction documentation and other matters necessary to consummate the Business Combination and (2) the election of the three Class I directors, two Class II directors and two Class III directors named in the proxy statement/prospectus, which includes the IRA Designees.
Read in the reply
Material U.S. Federal Income Tax Consequences, page 96
SEC asked (8)
Please refer to comment 14, and comment 25 from our December 17, 2020 letter. Your discussion of tax consequences describes the law in great detail without clearly stating the tax consequences to U.S. holders, by including the consequences to U.S. holders among the discussion of the tax treatment of the overall merger/business combination. Revise to be more clear by separating the two.
Rest of the question

When revising, please clarify the reasons for the sometimes addressing the "Business Combination," rather than the "RH Merger," as you use both terms in this section. We note the definitions of those terms in the letter to shareholders. Please revise to clarify, if accurate, that counsel's opinion that the the merger/combination should be a non-recognition event under Section 351, is a determination distinct from counsel's opinion that the merger/business combination more likely than not qualifies as a reorganization under Section 368. In doing so, explain the uncertainties within each of those determinations. For example, briefly explain the "events or actions that occur following the Business Combination that are beyond [y]our control" that could impact the determination. Then please highlight and clearly state the tax consequences to U.S. holders of common stock and warrants under each scenario, including whether they redeem or exchange their shares or warrants, explaining uncertainties in those determinations. As counsel's opinion, included in Exhibit 8.1, speaks only as to the tax consequences described in "Material U.S. Federal Income Tax Considerations—U.S. Holders—The Business Combination," address all material tax consequences in that subsection, rather than by cross-reference elsewhere. We do not object if you urge security holders to consult a tax professional regarding the consequences of their particular situation. Finally, please clarify, if true, that the Taxation of Distributions on ParentCo Common Stock relates to future dividends, that the "Gain or Loss on Sale, Taxable Exchange or Other Taxable Disposition of ParentCo Securities" relates to future sales or dispositions, and to sufficiently distinguish those sections from the discussion of the consequences of the business combination/merger and related redemption or exchange.

PCT answered
Changes in response to the Staff’s comment are reflected on pages 97 through 105 of the Amended Registration Statement and on Exhibit 8.1 to the Amended Registration Statement.
Read in the reply
Description of PCT Business, page 105
SEC asked (9)
We reissue comment 26 of our initial letter. In your next amendment, revise to provide the information on the principal holders of PCT securities as required by Item 403 of Regulation S-K.
PCT answered
Changes in response to the Staff’s comment are reflected on pages 156 through 159 of the Amended Registration Statement.
Read in the reply
Description of PCT Business · Intellectual Property, page 116
SEC asked (10)
We note the added disclosure of the sublicense agreement with Impact Recycling Limited, and the addendum to the agreement. File these agreements as exhibits to the registration statement as required by Item 601(b) of Regulation S-K or tell us why you believe they are not required to be filed. Revise to more specifically quantify the "certain license fees and royalties" and the term of the agreement.
PCT answered
Changes in response to the Staff’s comment are reflected on pages 118, 119, 134 and 135 of the Amended Registration

Statement. The Impact Recycling Limited sublicense agreement and related addendum are filed as Exhibits 10.27, 10.28 and 10.29 to the Amended Registration Statement.

Securities Ownership of Certain Beneficial Owners and Management,
Read in the reply
Securities Ownership of Certain Beneficial Owners and Management, page 205
SEC asked (11)
Please identify the natural person or persons who directly or indirectly exercise sole or shared voting and/or dispositive power with respect to the common stock held by Pure Crown LLC. Refer to Item 403 of Regulation S-K.
PCT answered
Changes in response to the Staff's comment are reflected on pages 158 and 215 of the Amended Registration Statement.

Additionally, the Company and PCT respectfully note that they believe that no natural person or persons directly or indirectly exercise sole or shared voting or dispositive power with respect to the equity securities held by Pure Crown LLC and, therefore, no such persons are required to be named.

PCT has been advised that Pure Crown LLC is managed by HCC Manager

LLC (“HCC Manager”) pursuant to the Limited Liability Company Agreement of Pure Crown LLC.
Rest of the answer

PCT has also been advised that voting and investment power over the equity securities managed by HCC Manager is exercised jointly by the three individuals who are the managers of HCC Manager, and voting and disposition decisions require the approval of a majority of such managers.

Accordingly, no single individual manager has a controlling decision and no individual manager of HCC Manager should be deemed a beneficial owner of the equity securities managed by HCC Manager and held by Pure Crown LLC.

We believe this view is consistent with the

Staff’s position in The Southland Corp. SEC No-Action Letter (July 8, 1987, publicly available August 10, 1987).

In that No-Action Letter, the Staff concurred in the view that no individual should be deemed the beneficial owner, within the meaning of Rule 13d-3 under the Exchange Act of 1934, as amended (the “Exchange Act”), of shares of common stock held by certain employee benefit plans of The Southland Corporation solely by virtue of the fact that such individual was a trustee of any such plan or a director of the company. Five trustees, who could only act by majority vote, administered each such plan. No trustee could act individually to vote or sell shares held by the plans. We also note that the “rule of three,” as articulated by Romeo & Dye in The Section 16 Treatise and Reporting Guide, 5th

Edition, in its analysis of beneficial ownership under Section 13(d) of the Exchange Act, based on The Southland Corp.

No-Action Letter supports this view. As the “rule of three” is stated therein, where voting and investment decisions regarding an entity’s portfolio securities are made by three or more individuals, and a voting or investment decision requires the approval of a majority of those individuals, then none of the individuals would be deemed a beneficial owner of the entity’s portfolio securities for purposes of Section 13(d) of the Exchange Act. Instruction 2 to Item 403 of Regulation S-K, promulgated under the Securities Act of 1933, as amended, provides that beneficial ownership shall be determined in accordance with Rule 13d-3 under the Exchange Act.

As discussed above, since voting and investment power over the equity securities managed by HCC Manager is exercised jointly by HCC Manager’s three managers and voting and disposition decisions require the approval of a majority of such managers, none of the managers would be deemed a beneficial owner of the equity securities managed by HCC Manager and held by Pure Crown LLC for purposes of Section 13(d). As such, beneficial ownership should not be attributed to any of HCC Manager’s three managers individually and none of the managers should be required to be named in the Amended Registration Statement in connection with the equity securities held by Pure Crown.

Read in the reply

Letters without questions

Other letters

UPLOAD and CORRESP
9 other letters: notices that a filing will not be reviewed, requests to declare a registration effective, and the like

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 20 letters filed since 2020-12-17. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PCT/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.